149 related articles for article (PubMed ID: 36520848)
1. Medically-attended anxiety and depression is increased among newly diagnosed patients with cold agglutinin disease: Analysis of an integrated claim-clinical cohort in the United States.
Broome CM; Hooda N; Su J; Jiang X; Nicholson G; Frankenfeld CL; Iglesias-Rodriguez M; Fryzek J; Patel P
PLoS One; 2022; 17(12):e0276617. PubMed ID: 36520848
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of thrombotic events in cold agglutinin disease: A 10-year retrospective analysis.
Broome CM; Cunningham JM; Mullins M; Jiang X; Bylsma LC; Fryzek JP; Rosenthal A
Res Pract Thromb Haemost; 2020 May; 4(4):628-635. PubMed ID: 32548562
[TBL] [Abstract][Full Text] [Related]
3. Healthcare resource utilization among patients with cold agglutinin disease in Denmark.
Vágó EK; Nicholson G; Horváth-Puhó E; Hooda N; Fryzek JP; Su J
Curr Med Res Opin; 2021 Oct; 37(10):1829-1835. PubMed ID: 34308723
[TBL] [Abstract][Full Text] [Related]
4. Healthcare resource utilization among commercially insured patients with cold agglutinin disease in the United States.
Su J; Bylsma LC; Jiang X; Morales Arias J; Jain N; Nordyke RJ
J Med Econ; 2020 Aug; 23(8):902-907. PubMed ID: 32362156
[No Abstract] [Full Text] [Related]
5. Complement-mediated hemolysis persists year round in patients with cold agglutinin disease.
Röth A; Fryzek J; Jiang X; Reichert H; Patel P; Su J; Morales Arias J; Broome CM
Transfusion; 2022 Jan; 62(1):51-59. PubMed ID: 34813663
[TBL] [Abstract][Full Text] [Related]
6. Occurrence, thromboembolic risk, and mortality in Danish patients with cold agglutinin disease.
Bylsma LC; Gulbech Ording A; Rosenthal A; Öztürk B; Fryzek JP; Arias JM; Röth A; Berentsen S
Blood Adv; 2019 Oct; 3(20):2980-2985. PubMed ID: 31648316
[TBL] [Abstract][Full Text] [Related]
7. Cold agglutinin-mediated autoimmune hemolytic anemia.
Berentsen S; Randen U; Tjønnfjord GE
Hematol Oncol Clin North Am; 2015 Jun; 29(3):455-71. PubMed ID: 26043385
[TBL] [Abstract][Full Text] [Related]
8. Demographic characteristics, thromboembolism risk, and treatment patterns for patients with cold agglutinin disease in Japan.
Kamesaki T; Nishimura JI; Wada H; Yu E; Tsao E; Morales J; Kanakura Y
Int J Hematol; 2020 Sep; 112(3):307-315. PubMed ID: 32608010
[TBL] [Abstract][Full Text] [Related]
9. Development of the Cold Agglutinin Disease Symptoms and Impact Questionnaire (CAD-SIQ).
Joly F; DasMahapatra P; DiBenedetti DB; Kosa K; Hill QA
Eur J Haematol; 2023 Aug; 111(2):211-219. PubMed ID: 37128840
[TBL] [Abstract][Full Text] [Related]
10. Complement-directed therapy for cold agglutinin disease: sutimlimab.
Broome CM
Expert Rev Hematol; 2023; 16(7):479-494. PubMed ID: 37256550
[TBL] [Abstract][Full Text] [Related]
11. Associations between food insecurity and psychotropic medication use among women living with HIV in the United States.
Whittle HJ; Wolfe WR; Sheira LA; Frongillo EA; Palar K; Merenstein D; Wilson TE; Adedimeji A; Cohen MH; Wentz EL; Tien PC; Weiser SD
Epidemiol Psychiatr Sci; 2020 Apr; 29():e113. PubMed ID: 32248873
[TBL] [Abstract][Full Text] [Related]
12. Complement Activation and Inhibition in Autoimmune Hemolytic Anemia: Focus on Cold Agglutinin Disease.
Berentsen S
Semin Hematol; 2018 Jul; 55(3):141-149. PubMed ID: 30032751
[TBL] [Abstract][Full Text] [Related]
13. Persistent angina: highly prevalent and associated with long-term anxiety, depression, low physical functioning, and quality of life in stable angina pectoris.
Jespersen L; Abildstrøm SZ; Hvelplund A; Prescott E
Clin Res Cardiol; 2013 Aug; 102(8):571-81. PubMed ID: 23636227
[TBL] [Abstract][Full Text] [Related]
14. Sutimlimab for treatment of cold agglutinin disease: why, how and for whom?
Berentsen S; Barcellini W; D'Sa S; Jilma B
Immunotherapy; 2022 Oct; 14(15):1191-1204. PubMed ID: 35946351
[TBL] [Abstract][Full Text] [Related]
15. Sutimlimab: A Complement C1s Inhibitor for the Management of Cold Agglutinin Disease-Associated Hemolysis.
Moore DC; Arnall JR
Ann Pharmacother; 2023 Aug; 57(8):970-977. PubMed ID: 36476151
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT.
Duffy L; Clarke CS; Lewis G; Marston L; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Mangin D; Moore M; Nazareth I; Wiles N; Bacon F; Bird M; Brabyn S; Burns A; Donkor Y; Hunt A; Pervin J; Lewis G
Health Technol Assess; 2021 Nov; 25(69):1-62. PubMed ID: 34842135
[TBL] [Abstract][Full Text] [Related]
17. Sustained inhibition of complement C1s with sutimlimab over 2 years in patients with cold agglutinin disease.
Röth A; Barcellini W; D'Sa S; Miyakawa Y; Broome CM; Michel M; Kuter DJ; Jilma B; Tvedt THA; Weitz IC; Yoo R; Jayawardene D; Vagge DS; Kralova K; Shafer F; Wardȩcki M; Lee M; Berentsen S
Am J Hematol; 2023 Aug; 98(8):1246-1253. PubMed ID: 37246953
[TBL] [Abstract][Full Text] [Related]
18. Depression, antidepressants, and the risk of non-valvular atrial fibrillation: A nationwide Danish matched cohort study.
Fenger-Grøn M; Vestergaard M; Pedersen HS; Frost L; Parner ET; Ribe AR; Davydow DS
Eur J Prev Cardiol; 2019 Jan; 26(2):187-195. PubMed ID: 30452291
[TBL] [Abstract][Full Text] [Related]
19. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.
Sheehan DV; Keene MS; Eaddy M; Krulewicz S; Kraus JE; Carpenter DJ
CNS Drugs; 2008; 22(11):963-73. PubMed ID: 18840035
[TBL] [Abstract][Full Text] [Related]
20. Increased psychological symptom burden in patients with pancreatic cancer: A population-based cohort study.
Dengsø KE; Andersen EW; Thomsen T; Hansen CP; Christensen BM; Hillingsø J; Dalton SO
Pancreatology; 2020 Apr; 20(3):511-521. PubMed ID: 31973981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
